Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07611136
Recruiting
Cerebral Small Vessel Disease Progression Dependent on Stroke Type
Not applicable · Germany · 1 site
Registry update: 28 May 2026
NCT07550270
Recruiting
Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients
Not applicable · 1 site
Registry update: 24 Apr 2026
NCT07922200
Recruiting
Biomarkers of Paired VNS
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07455851
Recruiting
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Phase 1/2 · Australia, Greece · 9 sites
Registry update: 5 Nov 2026
NCT06398847
Recruiting
Virtual Reality (VR) Self-Hypnosis Software
Not applicable · United States · 1 site
Registry update: 27 Jul 2026
NCT07246057
Recruiting
Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships
Not applicable · United States · 1 site
Registry update: 14 Aug 2026
NCT07270978
Recruiting
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
Phase 1 · United States · 1 site
Registry update: 11 May 2026
NCT07415044
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Argentina, Brazil, Canada, China, Colombia, Czechia, France, Greece, Croatia, Hungary, Israel, India, Italy, Japan, South Korea, Lithuania, Latvia, Mexico, Poland, Puerto Rico, Portugal, Serbia, Slovakia, Taiwan, Ukraine, United States, South Africa · 258 sites
Registry update: 4 Nov 2026
NCT07362303
Recruiting
Neuralert Stroke Monitor Trial
Not applicable · United States · 1 site
Registry update: 1 Apr 2026
NCT07354971
Recruiting
IMMUNO-FIT Observational Study
Not applicable · United Kingdom · 1 site
Registry update: 28 Apr 2026
NCT07146906
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Phase 2 · Brazil, China, Czechia, Germany, Spain, Italy, Japan, South Korea, Poland, Taiwan, United States · 30 sites
Registry update: 21 Oct 2026
NCT07059494
Recruiting
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Phase 4 · United States · 1 site
Registry update: 28 Jul 2026
NCT07791862
Recruiting
Familial Inflammatory Bowel Disease Early Risk
Not applicable · United States · 1 site
Registry update: 28 Aug 2026
NCT07388563
Recruiting
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Phase 1 · United States · 1 site
Registry update: 20 Oct 2026
NCT07120776
Recruiting
Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial
Not applicable · United Kingdom · 1 site
Registry update: 22 May 2026
NCT07493317
Recruiting
Neutralizing Interleukin (IL)-6
Phase 2 · United States · 1 site
Registry update: 29 Apr 2026
NCT07601464
Recruiting
Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal Ablation
Not applicable · Italy · 1 site
Registry update: 22 May 2026
NCT07886957
Recruiting
AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography
Not applicable · Netherlands · 1 site
Registry update: 21 Oct 2026
NCT07293351
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Phase 1/2 · Argentina, Australia, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Spain, Finland, France, United Kingdom, Ireland, Italy, Japan, South Korea, Mexico, Romania, United States · 96 sites
Registry update: 23 Oct 2026
NCT07482501
Recruiting
Repetitive Transcranial Magnetic Stimulation in Cardiac Autonomic Dysfunction
Not applicable · 1 site
Registry update: 25 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.